Page 20 - journal_14-2_Full

122

/webdb.dmsc.moph.go.th/ifc_toxic/a_tx_1_001c.asp? An open-label extension study to investigate the long-
info_id=392 term safety and tolerability of THC/CBD oromucosal spray
6. °Õßæ—≤π“»—°¬¿“溟â∫√‘‚¿§ ”π—°ß“π§≥–°√√¡°“√ and oromucosal THC spray in patients with terminal cancer-
Õ“À“√·≈–¬“ °√–∑√«ß “∏“√≥ ÿ¢. ¬“‡ æμ‘¥„Àâ‚∑… related pain refractory to strong opioid analgesics. J Pain
[ÕÕπ‰≈πå]. 2548. [22 °√°Æ“§¡ 2559]; ‡¢â“∂÷߉¥â®“°: http:/ Symptom Manage. 2013;46(2):207-18.
/webnotes.fda.moph.go.th/consumer/csmb/csmb2548.nsf/ 19. Vara D, Salazar M, Olea-Herrero N, Guzmán M, Velasco
7. Hillig KW, Mahlberg PG. A chemotaxonomic analysis of G, Díaz-Laviada I. Anti-tumoral action of cannabinoids on
cannabinoid variation in Cannabis (Cannabaceae). Am J hepatocellular carcinoma: role of AMPK-dependent
Bot. 2004;91(6):966-75. activation of autophagy. Cell Death Differ. 2011;18(7):1099-
8. National Institute on Drug Abuse. Marijuana [Internet]. 111.
2016 February [cited 2016 July 22]; Available from: https:/ 20. Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A.
/www.drugabuse.gov/drugs-abuse/marijuana. Cannabidiol induces programmed cell death in breast cancer
9. æ√–√“™∫—≠≠—쑬“‡ æμ‘¥„Àâ‚∑… æ.». 2522. √“™°‘®®“ cells by coordinating the cross-talk between apoptosis
πÿ‡∫°…“‡≈à¡∑’Ë 96, μÕπ∑’Ë 93. (≈ß«—π∑’Ë 22 ‡¡…“¬π 2522). and autophagy. Mol Cancer Ther. 2011;10(7):1161-72.
10. Sutton IR, Daeninck P. Cannabinoids in the management 21. Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti
of intractable chemotherapy-induced nausea and vomiting C, Moreno-Bueno G, et al. Cannabinoids reduce ErbB2-
and cancer-related pain. J Support Oncol. 2006;4(10):531- driven breast cancer progression through Akt inhibition.
5. Mol Cancer. 2010;9:196.
11. Ahmedzai S, Carlyle DL, Calder IT, Moran F. Anti-emetic 22. McAllister SD, Murase R, Christian RT, Lau D, Zielinski
efficacy and toxicity of nabilone, a synthetic cannabinoid, AJ, Allison J, et al. Pathways mediating the effects of
in lung cancer chemotherapy. Br J Cancer. 1983;48(5):657- cannabidiol on the reduction of breast cancer cell
63. proliferation, invasion, and metastasis. Breast Cancer Res
12. Chan HS, Correia JA, MacLeod SM. Nabilone versus Treat. 2011;129(1):37-47.
prochlorperazine for control of cancer chemotherapy- 23. Romano B, Borrelli F, Pagano E, Cascio MG, Pertwee
induced emesis in children: a double-blind, crossover trial. RG, Izzo AA. Inhibition of colon carcinogenesis by a
Pediatrics. 1987;79(6):946-52. standardized Cannabis sativa extract with high content of
13. Johansson R, Kilkku P, Groenroos M. A double-blind, cannabidiol. Phytomedicine. 2014;21(5):631-9.
controlled trial of nabilone vs. prochlorperazine for refractory 24. Ramer R, Bublitz K, Freimuth N, Merkord J, Rohde H,
emesis induced by cancer chemotherapy. Cancer Treat Haustein M, et al. Cannabidiol inhibits lung cancer cell
Rev. 1982;9 Suppl B:25-33. invasion and metastasis via intercellular adhesion molecule-
14. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, 1. FASEB J. 2012;26(4):1535-48.
Mailliard JA, et al. Dronabinol versus megestrol acetate 25. Bifulco M, Laezza C, Pisanti S, Gazzerro P. Cannabinoids
versus combination therapy for cancer-associated anorexia: and cancer: pros and cons of an antitumour strategy. Br J
a North Central Cancer Treatment Group study. J Clin Pharmacol. 2006;148(2):123-35.
Oncol. 2002;20(2):567-73. 26. Preet A, Ganju RK, Groopman JE. Delta9-Tetrahydro-
15. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, cannabinol inhibits epithelial growth factor-induced lung
Yangco B, et al. Dronabinol as a treatment for anorexia cancer cell migration in vitro as well as its growth and
associated with weight loss in patients with AIDS. J Pain metastasis in vivo. Oncogene. 2008;27(3):339-46.
Symptom Manage. 1995;10(2):89-97. 27. Aviello G, Romano B, Borrelli F, Capasso R, Gallo L, Piscitelli
16. Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. F, et al. Chemopreventive effect of the non-psychotropic
Cannabinoid-opioid interaction in chronic pain. Clin phytocannabinoid cannabidiol on experimental colon cancer.
Pharmacol Ther. 2011;90(6):844-51. J Mol Med (Berl). 2012;90(8):925-34.
17. Jochimsen PR, Lawton RL, VerSteeg K, Noyes R Jr. Effect 28. Massa F, Marsicano G, Hermann H, Cannich A, Monory
of benzopyranoperidine, a delta-9-THC congener, on pain. K, Cravatt BF, et al. The endogenous cannabinoid system
Clin Pharmacol Ther. 1978;24(2):223-7. protects against colonic inflammation. J Clin Invest.
18. Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. 2004;113(8):1202-9.